CSTONE PHARMA-B to Present Three Self-Developed Pipeline Findings at Prestigious Global Oncology Conference

Stock News
03/18

CSTONE PHARMA-B (02616) announced that preclinical research findings from three of its internally developed drug pipelines have been selected for poster presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The AACR Annual Meeting is one of the most influential academic conferences in the global field of cancer research. The 2026 conference will be held from April 17 to April 22 at the San Diego Convention Center in California, USA. Related research abstracts will be published on April 3, 2026, in the AACR's official journal, *Cancer Research*.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10